Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Capital Employed: 2013-2025

Historic Return on Capital Employed for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to -0.35%.

  • Enanta Pharmaceuticals' Return on Capital Employed rose 2.00% to -0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.35%, marking a year-over-year increase of 2.00%. This contributed to the annual value of -0.30% for FY2025, which is 3.00% up from last year.
  • Enanta Pharmaceuticals' Return on Capital Employed amounted to -0.35% in Q3 2025, which was up 2.70% from -0.36% recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Return on Capital Employed ranged from a high of -0.19% in Q1 2021 and a low of -0.42% during Q1 2023.
  • Its 3-year average for Return on Capital Employed is -0.37%, with a median of -0.36% in 2025.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 21bps in 2021, then grew by 5bps in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.32% in 2021, then fell by 5bps to -0.36% in 2022, then decreased by 1bps to -0.37% in 2023, then rose by 2bps to -0.35% in 2024, then increased by 2bps to -0.35% in 2025.
  • Its Return on Capital Employed was -0.35% in Q3 2025, compared to -0.36% in Q2 2025 and -0.35% in Q1 2025.